F
Favas
About Favas
Data last updated:
Favas is a Director at Hebsi Private Limited (since 2019), Partner at Jedco Developers Llp (since 2023) and Designated Partner at Phase Pharma Llp (since 2022). The companies operate in Healthcare, Construction and Paper. The largest current company by reported revenue is Hebsi Private Limited at ₹42,560 (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hebsi Private Limited U85110KL2019PTC058588 | Director | 27 Jun 2019 | 2019 | ₹42,560 (FY 2020) | Active |
| Jedco Developers Llp AAE-9064 | Partner | 09 Jan 2023 | 2015 | Active | |
| Phase Pharma Llp ABZ-3844 | Designated Partner | 09 Dec 2022 | 2022 | Active |
Board colleagues of Favas
| Name | DIN | Company | Designation |
|---|---|---|---|
| Lubna Rahman Achankandy | 08495428 | Hebsi Private Limited | Director |
| Padingharan Achiyaveedu Mohammed Fasal | 07355990 | Jedco Developers Llp | Designated Partner |
| Shahdad Kadambott Abdurahiman | 07078154 | Jedco Developers Llp | Designated Partner |
| Shameer Azeez Manappurath Abdul | 07078193 | Jedco Developers Llp | Designated Partner |
| Abdulrahman Dhany | 10032701 | Phase Pharma Llp | Designated Partner |
| Athiyanathil Naeem | 08256615 | Phase Pharma Llp | Designated Partner |
| Mohamad Ismael Kakkengal | 10032698 | Phase Pharma Llp | Designated Partner |
| Othayoth Kollandi Faris | 10032699 | Phase Pharma Llp | Designated Partner |
| Umar Muniyammu | 10032702 | Phase Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Favas
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Favas
Favas currently holds 3 directorships: Hebsi Private Limited (Director, since 27 Jun 2019, revenue ₹42,560 (FY 2020)); Jedco Developers Llp (Partner, since 09 Jan 2023); Phase Pharma Llp (Designated Partner, since 09 Dec 2022).
Favas was first appointed on 27 Jun 2019 as Director at Hebsi Private Limited. The most recent appointment on record is 09 Jan 2023 at Jedco Developers Llp.
The current boards of Favas's companies include Lubna Rahman Achankandy (Hebsi Private Limited), Padingharan Achiyaveedu Mohammed Fasal (Jedco Developers Llp), Shahdad Kadambott Abdurahiman (Jedco Developers Llp), Shameer Azeez Manappurath Abdul (Jedco Developers Llp), Abdulrahman Dhany (Phase Pharma Llp), Athiyanathil Naeem (Phase Pharma Llp), among others.